BioDlink reports stable issued share capital for October

BioDlink International Company Limited submitted its monthly return for October 2025, showing no change in its total number of issued ordinary shares. The company maintained 772,787,887 ordinary shares at both the beginning and end of the month. No new shares were issued, nor were any treasury shares acquired or disposed of during the period.

The company's Pre-IPO Share Option Scheme, adopted on February 20, 2013, saw a decrease of 60,000 lapsed options during the month, reducing the outstanding options from 7,819,600 to 7,759,600. No new shares were issued as a result of exercised options, and no treasury shares were involved in any exercise.

Consequently, the total funds raised during the month from the exercise of options remained at $0. The report confirmed that all regulatory requirements for securities movements were met and that all issued shares are identical in rights and entitlements.